Troubling Hope: Religious Faith and False Hope in Clinical Research Participants

Area of Science:

• Bioethics
• Clinical Trials Ethics
• Oncology Research

Background:

• Hope in oncology research is often viewed as problematic, potentially indicating irrationality or misunderstanding.
• This perception raises concerns about participant vulnerability to exploitation and the validity of informed consent.
• Some argue for rejecting participants in early-phase oncology trials if their hope for benefit suggests a lack of decision-making capacity.

Purpose of the Study:

• To examine the relationship between hope, rationality, and voluntary decision-making in the context of oncology research ethics.
• To explore how religious faith and terminal illness influence these considerations.
• To challenge the automatic rejection of potential participants based solely on their hope for benefit.

Main Methods:

• Ethical analysis of hope in oncology research.
• Consideration of decision-making capacity in vulnerable populations.
• Exploration of the role of religious beliefs in research participation.

Main Results:

• Hope in oncology research participants is not necessarily indicative of irrationality or impaired decision-making capacity.
• Concerns about exploitation and consent validity stem from the context of hope, not hope itself.
• Religious faith can be a valid reason for participating in clinical trials, even in terminal illness.

Conclusions:

• Potential participants in phase I oncology trials should not be rejected due to hope for medical benefit.
• Informed consent and voluntary decision-making can coexist with hope, even when influenced by religious faith.
• Support for moral deliberation is crucial for participants, particularly those relying on religious reasons.